Skip to main content
. 2021 Jun 6;28(6):1273–1282. doi: 10.1007/s12282-021-01264-7

Table 1.

Patients’ characteristics

Patients N = 99
Age (years), M (range) 42 (22–66)
BMI (kg/m2), M (range) 23.5 (15.6–32.5)
BMI (kg/m2), (N, %)
 < 18.5 5 (5.0%)
 18.5–24.9 61 (61.6%)
 25–29.9 28 (28.4%)
 30–34.9 5 (5.0%)
Diabetes mellitus (N, %) 1 (1.0%)
Coagulation disorder (N, %) 5 (5.1%)
Active smoker (N, %) 22 (22.2%)
Preoperative chemotherapy (N, %) 51 (51.5%)
Preoperative radiation (N, %) 53 (53.5%)
Indication for breast reconstruction (N, %)
 Therapeutic mastectomy due to breast cancer 82 (82.8%)
  Idiopathic 49 (49.5%)
  BRCA1 or BRCA2 gene mutation 33 (33.3%)
 Prophylactic mastectomy (BRCA1 or BRCA2) 14 (14.2%)
 Poland syndrome (N, %) 1 (1.0%)
 Breast aplasia (N, %) 1 (1.0%)
 Mastopathy (N, %) 1 (1.0%)
Reconstruction laterality (N, %)
 Unilateral 39 (39.4%)
 Bilateral 60 (60.6%)

N number, M mean, BMI body mass index